The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

ockelly

Forum Topics Started

Viewing 6 topics - 1 through 6 (of 6 total)

- TOPIC
- GSK DERMA (MAGE A3) clinical trial ???
  Started by: ockelly General Melanoma Community
- 3
- 46
- Linny
  
  14 years, 3 months ago
- Help for Interferon aches and pains
  Started by: ockelly General Melanoma Community
- 1
- 2
- DeniseK
  
  14 years, 3 months ago
- Turmeric/Curcumin
  Started by: ockelly General Melanoma Community
- 3
- 6
- ockelly
  
  14 years, 5 months ago
- New Melanoma Therapy App
  Started by: ockelly General Melanoma Community
- 2
- 4
- EmilyandMike
  
  14 years, 10 months ago
- Starting Interferon.. any suggestions to decrease side effects
  Started by: ockelly General Melanoma Community
- 4
- 8
- Phil S
  
  14 years, 10 months ago
- When to start Interferon?
  Started by: ockelly General Melanoma Community
- 4
- 12
- joy_
  
  14 years, 10 months ago

Viewing 6 topics - 1 through 6 (of 6 total)

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.